Sanofi and Regeneron’s immunology blockbuster Dupixent was knocked down into second place as Eli Lilly’s diabetes medicine Trulicity took the top spot for January’s biggest TV ad spenders, according ...

Eli Lilly is officially the first pharma to add pricing information to a TV commercial. The move—initially for Trulicity in a spot that debuted this week—will expand to its other TV-promoted drugs by ...

Eli Lilly and Co. has the dubious distinction of receiving the first untitled letter in 2022 from the FDA’s Office of Prescription Drug Promotion. The letter, sent Jan. 19 and posted this week, takes ...

The FDA sent a letter to Eli Lilly scolding the drugmaker for Instagram ads it posted for its Type 2 diabetes drug Trulicity. In the letter, dated Jan. 19, the FDA said the ads do not adequately ...